Get Premium to unlock powerful stock data

Eversept Partners, LP Buys Laboratory Corp of America Holdings, Ascendis Pharma A/S, Community Health Systems Inc, Sells Qiagen NV, Amarin Corp PLC, Organon

Author's Avatar
insider
Nov 15, 2021
Article's Main Image
Investment company Eversept Partners, LP (Current Portfolio) buys Laboratory Corp of America Holdings, Ascendis Pharma A/S, Community Health Systems Inc, Catalent Inc, Icon PLC, sells Qiagen NV, Amarin Corp PLC, Organon, Danaher Corp, Omnicell Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Eversept Partners, LP. As of 2021Q3, Eversept Partners, LP owns 100 stocks with a total value of $1.3 billion. These are the details of the buys and sells.

For the details of Eversept Partners, LP's stock buys and sells, go to https://www.gurufocus.com/guru/eversept+partners%2C+lp/current-portfolio/portfolio

These are the top 5 holdings of Eversept Partners, LP
  1. United Therapeutics Corp (UTHR) - 444,471 shares, 6.24% of the total portfolio. Shares added by 0.34%
  2. Ascendis Pharma A/S (ASND) - 445,203 shares, 5.39% of the total portfolio. Shares added by 84.14%
  3. Community Health Systems Inc (CYH) - 5,988,163 shares, 5.33% of the total portfolio. Shares added by 56.69%
  4. Horizon Therapeutics PLC (HZNP) - 634,670 shares, 5.28% of the total portfolio. Shares reduced by 4.81%
  5. Acceleron Pharma Inc (XLRN) - 349,494 shares, 4.57% of the total portfolio. Shares added by 4.31%
New Purchase: Laboratory Corp of America Holdings (LH)

Eversept Partners, LP initiated holding in Laboratory Corp of America Holdings. The purchase prices were between $274.82 and $308.34, with an estimated average price of $293.32. The stock is now traded at around $286.920000. The impact to a portfolio due to this purchase was 2.74%. The holding were 128,311 shares as of 2021-09-30.

New Purchase: Catalent Inc (CTLT)

Eversept Partners, LP initiated holding in Catalent Inc. The purchase prices were between $109.17 and $142.35, with an estimated average price of $124.9. The stock is now traded at around $128.500000. The impact to a portfolio due to this purchase was 1.86%. The holding were 184,299 shares as of 2021-09-30.

New Purchase: Icon PLC (ICLR)

Eversept Partners, LP initiated holding in Icon PLC. The purchase prices were between $208.53 and $283.04, with an estimated average price of $242.91. The stock is now traded at around $282.940000. The impact to a portfolio due to this purchase was 1.43%. The holding were 71,911 shares as of 2021-09-30.

New Purchase: Masimo Corp (MASI)

Eversept Partners, LP initiated holding in Masimo Corp. The purchase prices were between $249 and $285.24, with an estimated average price of $270.95. The stock is now traded at around $298.580000. The impact to a portfolio due to this purchase was 1.38%. The holding were 67,000 shares as of 2021-09-30.

New Purchase: Sanofi SA (SNY)

Eversept Partners, LP initiated holding in Sanofi SA. The purchase prices were between $47.89 and $53.12, with an estimated average price of $50.89. The stock is now traded at around $51.160000. The impact to a portfolio due to this purchase was 0.95%. The holding were 259,128 shares as of 2021-09-30.

New Purchase: PerkinElmer Inc (PKI)

Eversept Partners, LP initiated holding in PerkinElmer Inc. The purchase prices were between $151.98 and $190.5, with an estimated average price of $176.11. The stock is now traded at around $183.640000. The impact to a portfolio due to this purchase was 0.62%. The holding were 47,081 shares as of 2021-09-30.

Added: Ascendis Pharma A/S (ASND)

Eversept Partners, LP added to a holding in Ascendis Pharma A/S by 84.14%. The purchase prices were between $112.67 and $176.92, with an estimated average price of $137.27. The stock is now traded at around $151.885000. The impact to a portfolio due to this purchase was 2.46%. The holding were 445,203 shares as of 2021-09-30.

Added: Community Health Systems Inc (CYH)

Eversept Partners, LP added to a holding in Community Health Systems Inc by 56.69%. The purchase prices were between $10.8 and $16.09, with an estimated average price of $13.08. The stock is now traded at around $14.790000. The impact to a portfolio due to this purchase was 1.93%. The holding were 5,988,163 shares as of 2021-09-30.

Added: McKesson Corp (MCK)

Eversept Partners, LP added to a holding in McKesson Corp by 115.61%. The purchase prices were between $188.42 and $208.66, with an estimated average price of $199.89. The stock is now traded at around $222.930000. The impact to a portfolio due to this purchase was 1.31%. The holding were 161,708 shares as of 2021-09-30.

Added: Avantor Inc (AVTR)

Eversept Partners, LP added to a holding in Avantor Inc by 32.56%. The purchase prices were between $35.36 and $44.01, with an estimated average price of $39.04. The stock is now traded at around $38.790000. The impact to a portfolio due to this purchase was 0.99%. The holding were 1,292,014 shares as of 2021-09-30.

Added: Maravai LifeSciences Holdings Inc (MRVI)

Eversept Partners, LP added to a holding in Maravai LifeSciences Holdings Inc by 337.08%. The purchase prices were between $36.8 and $60.62, with an estimated average price of $48.78. The stock is now traded at around $37.270000. The impact to a portfolio due to this purchase was 0.94%. The holding were 327,810 shares as of 2021-09-30.

Added: Guardant Health Inc (GH)

Eversept Partners, LP added to a holding in Guardant Health Inc by 5447.87%. The purchase prices were between $98.77 and $132.17, with an estimated average price of $119.09. The stock is now traded at around $102.025000. The impact to a portfolio due to this purchase was 0.93%. The holding were 100,361 shares as of 2021-09-30.

Sold Out: Organon & Co (OGN)

Eversept Partners, LP sold out a holding in Organon & Co. The sale prices were between $28.63 and $35.64, with an estimated average price of $32.03.

Sold Out: Omnicell Inc (OMCL)

Eversept Partners, LP sold out a holding in Omnicell Inc. The sale prices were between $141.84 and $160.88, with an estimated average price of $153.23.

Sold Out: Vertex Pharmaceuticals Inc (VRTX)

Eversept Partners, LP sold out a holding in Vertex Pharmaceuticals Inc. The sale prices were between $181.39 and $202.99, with an estimated average price of $195.37.

Sold Out: Cigna Corp (CI)

Eversept Partners, LP sold out a holding in Cigna Corp. The sale prices were between $200.16 and $238.3, with an estimated average price of $217.75.

Sold Out: Option Care Health Inc (OPCH)

Eversept Partners, LP sold out a holding in Option Care Health Inc. The sale prices were between $19.98 and $28.17, with an estimated average price of $23.25.

Sold Out: Affimed NV (AFMD)

Eversept Partners, LP sold out a holding in Affimed NV. The sale prices were between $5.54 and $7.51, with an estimated average price of $6.59.



Here is the complete portfolio of Eversept Partners, LP. Also check out:

1. Eversept Partners, LP's Undervalued Stocks
2. Eversept Partners, LP's Top Growth Companies, and
3. Eversept Partners, LP's High Yield stocks
4. Stocks that Eversept Partners, LP keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus